Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong
· Delayed Price · Currency is HKD
239.00
+17.20 (7.75%)
At close: Apr 29, 2026
HKG:2637 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | - | 136.08 | 117.45 | 68.98 |
| Depreciation & Amortization | - | 4.98 | 3.89 | 2.81 |
| Loss (Gain) From Sale of Assets | - | - | 0.03 | 0.02 |
| Loss (Gain) From Sale of Investments | - | -1.14 | - | 0.14 |
| Stock-Based Compensation | - | 0 | 0.01 | 0.03 |
| Provision & Write-off of Bad Debts | - | 0.13 | 0.67 | -0.06 |
| Other Operating Activities | - | 15.4 | 23.24 | 29.24 |
| Change in Accounts Receivable | - | -22.78 | -25.47 | 5.62 |
| Change in Inventory | - | -10.41 | 3.4 | -5.54 |
| Change in Accounts Payable | - | 33.9 | 25.61 | -13.2 |
| Change in Unearned Revenue | - | 7.78 | -1.72 | -2.73 |
| Operating Cash Flow | - | 163.94 | 147.11 | 85.31 |
| Operating Cash Flow Growth | - | 11.45% | 72.44% | - |
| Capital Expenditures | - | -178.56 | -58.71 | -3.07 |
| Sale (Purchase) of Real Estate | - | - | -0.78 | -28.63 |
| Investment in Securities | - | -244.13 | 100.42 | -22.04 |
| Other Investing Activities | - | 43.98 | -53.69 | -0.02 |
| Investing Cash Flow | - | -378.72 | -12.77 | -53.76 |
| Long-Term Debt Issued | - | 17.83 | 5.57 | - |
| Long-Term Debt Repaid | - | -4.83 | -46.91 | -9.84 |
| Net Debt Issued (Repaid) | - | 13 | -41.34 | -9.84 |
| Issuance of Common Stock | - | - | - | 157.6 |
| Other Financing Activities | - | -14.27 | -10.15 | -14.63 |
| Financing Cash Flow | - | -1.27 | -51.49 | 133.13 |
| Net Cash Flow | - | -216.04 | 82.85 | 164.68 |
| Free Cash Flow | - | -14.62 | 88.39 | 82.24 |
| Free Cash Flow Growth | - | - | 7.47% | - |
| Free Cash Flow Margin | - | -3.13% | 27.92% | 38.71% |
| Free Cash Flow Per Share | - | -0.22 | 1.31 | 1.28 |
| Cash Interest Paid | - | 13.43 | 10.15 | 14.63 |
| Cash Income Tax Paid | - | 4.28 | 0.01 | - |
| Levered Free Cash Flow | - | -57.3 | 59.52 | - |
| Unlevered Free Cash Flow | - | -52.79 | 64.36 | - |
| Change in Working Capital | - | 8.5 | 1.81 | -15.85 |
Source: S&P Capital IQ. Standard template.
Financial Sources.